Literature DB >> 3279109

Bone disease after orthotopic liver transplantation.

E B Haagsma1, C J Thijn, J G Post, M J Slooff, C H Gips.   

Abstract

After orthotopic liver transplantation (OLT), not infrequently a deterioration of bone disease leading to compression fractures of vertebrae is seen. In a consecutive series of 36 adult OLT patients, we studied, clinically and radiologically, the incidence and degree of bone disease before and after OLT; we also studied whether clinical, radiological and laboratory findings were related to the event of postoperative vertebral collapse. Before OLT, radiological signs of mostly slight osteoporosis were seen in a minority of patients. After OLT, 38% of patients developed vertebral collapse, mainly in the second trimester. Collapse occurred in both previously normal and abnormal vertebrae. Of the preoperative parameters sex, age, menopause, intake of prednisolone, duration and diagnosis of liver disease, duration and degree of cholestasis, bone radiology and urinary calcium, only a low urinary calcium was related to postoperative collapse. Of the postoperative parameters duration of cholestasis, urinary calcium, duration of hospital stay, prednisolone dose and outcome in terms of life and death, none was related to collapse. We conclude that vertebral collapse after OLT occurs frequently and is not easily predicted. Early prevention of bone disease in patients with chronic liver disease before OLT and a low steroid-containing immunosuppressive regimen after OLT are advocated.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3279109     DOI: 10.1016/s0168-8278(88)80467-7

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  12 in total

Review 1.  Bone disease after liver transplantation.

Authors:  M S Losowsky; S H Hussaini
Journal:  Gut       Date:  1996-10       Impact factor: 23.059

2.  Bone loss after liver transplantation is not prevented by cyclical etidronate, calcium and alphacalcidol. The Liver Transplant Group, Groningen.

Authors:  S C Riemens; A Oostdijk; J J van Doormaal; C J Thijn; G Drent; D A Piers; E W Groen; L Meerman; M J Slooff; E B Haagsma
Journal:  Osteoporos Int       Date:  1996       Impact factor: 4.507

3.  Collapsing focal segmental glomerulosclerosis in a liver transplant recipient on alendronate.

Authors:  J Pascual; J Torrealba; J Myers; S Tome; M Samaniego; A Musat; A Djamali
Journal:  Osteoporos Int       Date:  2007-04-03       Impact factor: 4.507

4.  Fracture incidence after liver transplantation: results of a 10-year audit.

Authors:  M O Premaor; T K Das; I Debiram; R A Parker; M Ninkovic; G T Alexander; J E Compston
Journal:  QJM       Date:  2011-03-08

5.  Early increase of bone resorption in patients with liver cirrhosis secondary to viral hepatitis.

Authors:  G R Corazza; F Trevisani; M Di Stefano; S De Notariis; G Veneto; L Cecchetti; L Minguzzi; G Gasbarrini; M Bernardi
Journal:  Dig Dis Sci       Date:  2000-07       Impact factor: 3.199

Review 6.  Advances in the management of corticosteroid-induced osteoporosis with bisphosphonates.

Authors:  Johann D Ringe; Parvis Farahmand
Journal:  Clin Rheumatol       Date:  2006-11-23       Impact factor: 2.980

7.  Predicting bone loss following orthotopic liver transplantation.

Authors:  O M Crosbie; R Freaney; M J McKenna; M P Curry; J E Hegarty
Journal:  Gut       Date:  1999-03       Impact factor: 23.059

Review 8.  Drug therapy in transplant recipients: special considerations in the elderly with comorbid conditions.

Authors:  José F Bernardo; Jerry McCauley
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

Review 9.  Osteoporosis after solid organ and bone marrow transplantation.

Authors:  Adi Cohen; Elizabeth Shane
Journal:  Osteoporos Int       Date:  2003-08-08       Impact factor: 4.507

10.  Chronic pain 1-5 years after heart transplantation-A nationwide cross-sectional cohort study.

Authors:  Marita Dalvindt; Annika Kisch; Shahab Nozohoor; Annette Lennerling; Anna Forsberg
Journal:  Nurs Open       Date:  2020-04-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.